An in vivo mechanism for the reduced peripheral neurotoxicity of NK105: a paclitaxel-incorporating polymeric micellar nanoparticle formulation.
about
An in vivo mechanism for the reduced peripheral neurotoxicity of NK105: a paclitaxel-incorporating polymeric micellar nanoparticle formulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An in vivo mechanism for the r ...... llar nanoparticle formulation.
@en
An in vivo mechanism for the r ...... llar nanoparticle formulation.
@nl
type
label
An in vivo mechanism for the r ...... llar nanoparticle formulation.
@en
An in vivo mechanism for the r ...... llar nanoparticle formulation.
@nl
prefLabel
An in vivo mechanism for the r ...... llar nanoparticle formulation.
@en
An in vivo mechanism for the r ...... llar nanoparticle formulation.
@nl
P2093
P2860
P356
P1476
An in vivo mechanism for the r ...... llar nanoparticle formulation.
@en
P2093
Akira Masuda
Daichi Nagai
Eiji Ichimura
Hirofumi Yokoyama
Hiroko Mashiba
Hitomi Hayashi
Iwao Nakamura
Takeshi Onda
P2860
P304
P356
10.2147/IJN.S114356
P407
P577
2017-02-15T00:00:00Z